Seeing Is Believing
ILMN is currently covered by 21 analysts with an average price target of $159.1. This is a potential upside of $22.43 (16.41%) from yesterday's end of day stock price of $136.67.
Illumina's activity chart (see below) currently has 372 price targets and 287 ratings on display. The stock rating distribution of ILMN is 39.13% HOLD, 50.72% BUY and 10.14% SELL.
Analysts average stock forecasts to be materialized ratio is 75.27% with an average time for these price targets to be met of 200.97 days.
Highest price target for ILMN is $185, Lowest price target is $125, average price target is $159.1.
Most recent stock forecast was given by TEJAS SAVANT from MORGAN STANLEY on 13-Jan-2025.
Illumina is a life science tools and integrated systems company that focuses on large-scale analysis of genetic variation and function. The company operates through two segments, Core Illumina and GRAIl:
The company’s Galleri test is a multi-cancer early detection test that can detect more than 50 types of cancer through a simple blood draw.
In addition to its products, Illumina provides a range of services including whole-genome sequencing, genotyping, non-invasive prenatal testing (NIPT), and product support services.
Illumina was incorporated in 1998 and is headquartered in San Diego, California.
Currently out of the existing stock ratings of ILMN, 27 are a HOLD (39.13%), 35 are a BUY (50.72%), 7 are a SELL (10.14%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$150
$13.33 (9.75%)
$156
5 days ago
(13-Jan-2025)
3/7 (42.86%)
$6.1 (4.24%)
75
Buy
$184
$47.33 (34.63%)
$170
2 months 6 days ago
(12-Nov-2024)
0/5 (0%)
$34.47 (23.05%)
Buy
$185
$48.33 (35.36%)
$195
2 months 7 days ago
(11-Nov-2024)
4/18 (22.22%)
$34.45 (22.88%)
75
Hold
$145
$8.33 (6.09%)
$135
2 months 13 days ago
(05-Nov-2024)
11/12 (91.67%)
$-6.15 (-4.07%)
150
Hold
$145
$8.33 (6.09%)
$130
2 months 13 days ago
(05-Nov-2024)
3/17 (17.65%)
$-6.15 (-4.07%)
34
What is ILMN (Illumina) average time for price targets to be met?
Which analyst has the current highest performing score on ILMN (Illumina) with a proven track record?
Which analyst has the most public recommendations on ILMN (Illumina)?
Which analyst is the currently most bullish on ILMN (Illumina)?
Which analyst is the currently most reserved on ILMN (Illumina)?